Navigation Links
VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting

BASKING RIDGE, N.J., April 19, 2007 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals, Inc. , a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted cancer compounds, announced data from its preclinical studies of VQD- 002, a direct inhibitor of Akt activation for the treatment of solid and hematologic tumors. Pre-clinical data was presented in a poster at the April 2007 Annual Meeting of the American Association for Cancer Research (AACR), held in Los Angeles, CA.

"We are very excited to see these findings presented at AACR for our direct Akt inhibitor, VQD-002, in combination with another targeted agent Cdk9. Given that VQD-002 has two Phase I/IIa monotherapy programs in solid and hematogical tumors; this compliments the body of evidence that strongly suggests that VQD-002 may work in combination with multiple agents. We are eager to use findings like this to help us design the undertaking of additional clinical trials in combination therapy in the second half of 2007. VQD-002 has also shown compelling preclinical activity in combination with other targeted therapies such as Herceptin (trastuzumab), and other tyrosine kinases used in the treatment in tumor types such as glioblastoma, lymphomas, refractory leukemias, breast, colon and non-small cell lung cancer," said Daniel Greenleaf, VioQuest's president and CEO.

"The pre-clinical data for VQD-002 presented at AACR showed that the compound, in combination with another targeted pathway inhibitor, roscovatine, repressed the growth of specific prostate cancer cells in vitro. This combination, which may inhibit the pathways of apoptosis (programmed cell death) and eventually have a clinical application in the treatment of prostatic cancer, was one of more than 400 publications provided at AACR, showing the importance of the Akt pathway in human cancer," said Dr. Edward Bradley, VioQuest's Chief S
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:7/29/2014)... LAKE CITY and ... -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an ... in the development of improved novel formulations ... active molecules announces expansion of its pharmaceutical ... new development direction includes large molecule drugs that ...
(Date:7/29/2014)... -- Cynosure, Inc. (Nasdaq: CYNO ... treatment systems for high-volume applications, today reported financial results ... 2014 financial results incorporate the acquisition of Palomar Medical ... Second-Quarter 2014 Financial Highlights ... , Non-GAAP net income of $7.1 million, or ...
(Date:7/29/2014)... IRVING, Texas , July 29, 2014 /PRNewswire/ ... three new web-based applications with breakthrough interactive features ... and workflows for members of Children,s Hospital Association.  ... under the Novation Optimize Solutions umbrella – Value ... of how Novation helps organizations address the most ...
Breaking Medicine Technology:EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5
... , DETROIT, Dec. 30 For the twelfth ... Church of Christ, is campaigning to save lives during New ... for the New Millennium, Health Alliance Plan (HAP) and the ... residents to celebrate the New Year without gunfire. The ...
... BOSTON, Dec. 30 Solos Endoscopy, Inc. (Pink Sheets: SNDY) ... prosperous 2010, following a solid year in 2009, due in great ... months of 2009, Solos Endoscopy, Inc. has taken the initial steps ... endoscopy instruments. This will allow the MammoView(TM) line to be sold ...
Cached Medicine Technology:Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Year's Eve Celebrations 2Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:7/29/2014)... July 29, 2014 Daily Gossip writes in ... and holistic system that will teach users how to permanently ... thousands of people, from all over the world. , ... of this disorder in as quickly as 12 hours. This ... faster than imagined. , The Fibroids Miracle review also ...
(Date:7/29/2014)... 29, 2014 Daily Gossip indicates in ... was actually created by a popular nutritionist and health ... numerous treatments for this disorder, but none of them ... the situation of having to look for an alternative ... Dawson used this method, too, to become vitiligo free. ...
(Date:7/29/2014)... (HealthDay News) --,The time at which heart attack patients ... survival, new research suggests. Showing up at the ... is associated with a 13 percent higher risk for ... Every year, more than 250,000 people suffer a ... heart attack, which is caused by a complete blockage ...
(Date:7/29/2014)... HealthDay Reporter TUESDAY, ... take on a task, various brain connections fire up. ... kids with autism, according to a small new study. ... displayed even less of this "brain flexibility," the researchers ... difficulty when children with autism are faced with new ...
(Date:7/29/2014)... July 29, 2014 As the Ebola outbreak ... its partners to both purchase critical emergency supplies locally, as ... to Liberia. These supplies will contain materials used to control ... heavily populated areas of the country. , With a ... the response to the Ebola outbreak in the region. The ...
Breaking Medicine News(10 mins):Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2Health News:Natural Vitiligo Treatment System Review Reveals Michael Dawson’s New Vitiligo Cure Program 2Health News:Heart Attack Patients Treated at Night, Weekends May Have Worse Outcomes 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 2Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 3
... Holdings,Inc. (Amex: ZTM ) announced today that ... placement subscription agreements pursuant to which we,sold 23.7 ... an,aggregate offering price of $2,370,000. Each of the ... of a $100,000 24-month,senior secured promissory note (each ...
... are overwhelmingly positive, PORTLAND, Ore., Sept. 3 ... their doctor to others, according to a,popular online ... myRegence.com. A,"Member Feedback" feature on the site allows ... individual providers, including,physicians, dentists, other health care professionals ...
... Amsterdam, September 3, 2008 A recent study (doi:10.1016/j.clim.2008.06.009) ... of the Clinical Immunology Society (CIS), describes a new ... human cells. The report demonstrates the characterization of specific ... providing information about the role these cells might play ...
... on earnings and productivity for healthcare professionals in the United States, ... decrease in patient loads. , ... New York, NY ... focusing on earnings and productivity for physicians in America features some ...
... Cancer Care System , In this report, the Cancer ... the quality of cancer care in America, presents a set ... cancer care and a "Blueprint" for actions to realize this ... best-case scenario for patients with various cancers and at key ...
... Patient Driven Medicine, Note: September is Pain ... Insurance,companies are denying Fibromyalgia patients proper access to ... a difficult time getting,their fibromyalgia patients the appropriate ... fast tracked prescription medicine,Lyrica and now Cymbalta, there ...
Cached Medicine News:Health News:Z Trim Holdings, Inc. Announces Private Placement Funding 2Health News:Z Trim Holdings, Inc. Announces Private Placement Funding 3Health News:Doctors Get High Marks as Regence Members Share Opinions Online 2Health News:Fresh Medical Industry News Reveals Earnings & Productivity Changes For Physicians 2Health News:News from CA: Cancer Quality Alliance, blueprint for a better cancer care system 2Health News:Important Information on Fibromyalgia and Access to Treatments 2Health News:Important Information on Fibromyalgia and Access to Treatments 3
... offers the ease and comfort you've come to ... users in clinical trials agreed that the BD ... depth settings allow you to choose the best ... of lancets, the device also helps eliminate the ...
... StaRRsed-III is a system that measures ... samples. This rate may be relevant ... The sedimentation rate is measured in ... typically used in high-volume settings such ...
... The StaRRsed Compact is a system ... human blood samples. This rate may ... patients therapy. The sedimentation rate is ... hence is typically used in high-volume ...
MiniVes has been specifically designed for the doctors office and near patient testing and it uses normally freshly collected blood that shall be mixed manually by 15 complete inversion of the tube a...
Medicine Products: